Body fluids and tissues offer a wealth of information on normal physiology and possible pathological disorders. Advances in proteomic technologies represent an opportunity to considerably increase our knowledge about the molecular changes that occur within a normal physiological state and throughout disease progression. Biognosys’ discovery proteomics (HRM-MS™) enables quantification of thousands of proteins per sample from virtually any fluid or tissue and the identification of significantly regulated proteins between normal and treatment conditions. These proteins of interest can then be validated using our targeted proteomics approach (MRM or PRM), where up to 100 proteins per sample can be accurately quantified on an absolute level in thousands of samples in a high-throughput mode.
You are likely to benefit if you are looking to:
- Discover critical disease biomarkers from blood, tissue or liquid biopsies using discovery proteomics
- Rapidly screen thousands of samples (blood, tissue or liquid biopsies) for the presence of up to several hundred protein biomarkers along with their relative or absolute quantitation using targeted proteomics